TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

Rosen Law Firm is pursuing a securities class action lawsuit against Telix Pharmaceuticals for allegedly making false statements about prostate cancer therapeutic candidates and supply chain quality during the period of February 21-August 28, 2025.

Insights
GRAB   neutral

Mentioned as an investor and ecosystem partner


TLX   negative

The lawsuit alleges the company made materially false and misleading statements about its prostate cancer therapeutic progress and supply chain quality, suggesting potential corporate misrepresentation and investor harm